|
Market Closed -
Other stock markets
|
After hours 00:37:00 | |||
| 352.82 USD | +0.40% |
|
345.30 | -2.13% |
| 06-25 | Major deals involving US drugmakers and biotechs over the past decade | RE |
| 06-22 | Amgen France Names a New Communications Director |  |
Company Valuation: Amgen Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 126,718 | 140,139 | 154,142 | 140,103 | 176,250 | 190,420 | - | - |
| Change | - | 10.59% | 9.99% | -9.11% | 25.8% | 8.04% | - | - |
| Enterprise Value (EV) 1 | 151,990 | 169,779 | 207,811 | 188,229 | 221,725 | 231,652 | 225,502 | 219,974 |
| Change | - | 11.7% | 22.4% | -9.42% | 17.8% | 4.48% | -2.65% | -2.45% |
| P/E | 21.9x | 21.7x | 23.1x | 34.5x | 23x | 22.9x | 20.9x | 19.9x |
| PBR | 18.7x | 38.3x | 24.7x | 23.8x | 20.4x | 17.1x | 13.6x | 10.8x |
| PEG | - | 1.2x | 7.36x | -0.9x | 0.3x | 2.83x | 2.11x | 4.15x |
| Capitalization / Revenue | 4.88x | 5.32x | 5.47x | 4.19x | 4.8x | 5.04x | 4.91x | 4.79x |
| EV / Revenue | 5.85x | 6.45x | 7.37x | 5.63x | 6.03x | 6.13x | 5.82x | 5.54x |
| EV / EBITDA | 9.61x | 10.5x | 11.9x | 9.13x | 10.4x | 10.7x | 10.4x | 10.5x |
| EV / EBIT | 12.2x | 13.3x | 15.5x | 12.5x | 13.7x | 14x | 13.2x | 12.6x |
| EV / FCF | 18.1x | 19.3x | 28.2x | 18.1x | 27.4x | 17.2x | 14.9x | 14.4x |
| FCF Yield | 5.51% | 5.17% | 3.54% | 5.52% | 3.65% | 5.8% | 6.7% | 6.96% |
| Dividend per Share 2 | 7.04 | 7.76 | 8.52 | 9 | - | 10.09 | 10.66 | 11.13 |
| Rate of return | 3.13% | 2.95% | 2.96% | 3.45% | - | 2.86% | 3.02% | 3.16% |
| EPS 2 | 10.28 | 12.11 | 12.49 | 7.56 | 14.23 | 15.38 | 16.91 | 17.72 |
| Distribution rate | 68.5% | 64.1% | 68.2% | 119% | - | 65.6% | 63% | 62.8% |
| Net sales 1 | 25,979 | 26,323 | 28,190 | 33,424 | 36,751 | 37,780 | 38,749 | 39,740 |
| EBITDA 1 | 15,822 | 16,178 | 17,470 | 20,620 | 21,370 | 21,638 | 21,587 | 21,007 |
| EBIT 1 | 12,424 | 12,761 | 13,399 | 15,028 | 16,203 | 16,507 | 17,026 | 17,494 |
| Net income 1 | 5,893 | 6,552 | 6,717 | 4,090 | 7,711 | 8,265 | 9,041 | 9,541 |
| Net Debt 1 | 25,272 | 29,640 | 53,669 | 48,126 | 45,475 | 41,232 | 35,083 | 29,554 |
| Reference price 2 | 224.97 | 262.64 | 288.02 | 260.64 | 327.31 | 352.82 | 352.82 | 352.82 |
| Nbr of stocks (in thousands) | 563,266 | 533,579 | 535,178 | 537,533 | 538,481 | 539,708 | - | - |
| Announcement Date | 07/02/22 | 31/01/23 | 06/02/24 | 04/02/25 | 03/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 22.94x | 6.13x | 10.71x | 2.86% | 190B | |
| 32.86x | 12x | 24.39x | 0.61% | 1,006B | |
| 26.17x | 6.03x | 16.39x | 2.18% | 589B | |
| 30.87x | 7.21x | 14.74x | 2.85% | 430B | |
| 17.87x | 4.45x | 10.93x | 2.99% | 331B | |
| 23.29x | 4.86x | 13.76x | 1.8% | 288B | |
| 21.56x | 5.56x | 13.49x | 2.84% | 285B | |
| 13.98x | 5.17x | 10.65x | 3.6% | 213B | |
| -44.37x | 5.36x | 29.56x | 2.62% | 154B | |
| 11.07x | 2.97x | 7.23x | 7.4% | 135B | |
| Average | 15.62x | 5.97x | 15.18x | 2.97% | 362.07B | |
| Weighted average by Cap. | 22.79x | 7.36x | 17.06x | 2.25% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- AMGN Stock
- Valuation Amgen Inc.
Select your edition
All financial news and data tailored to specific country editions
